The nucleotide sequence of the Serratia narcescens threonine operon (thrA$,2BC) was determined. Three long open reading frames were identified; these open reading frames code for aspartokinase I (AKI)-homoserine dehydrogenase I (HDI), homoserine kinase, and threonine synthase, in that order. The predicted amino acid sequences of these enzymes were similar to the amino acid sequences of the corresponding enzymes in Escherichia coli. The AKI-HDI protein is apparently a tetramer composed of monomer polypeptides that are 819 amino acids long. A deletion analysis revealed that the central and C-terminal region was responsible for threonine-resistant HDI activity, a monomeric fragment extending from the N terminus to residue 306 was responsible for threonine-resistant AKI activity, and an N-terminal portion containing 468 residues was responsible for threonine-sensitive AKI activity. The thrAlIA21 and thrA15A25 mutations of threonineexcreting strains HNr21 and TLr156, which result in the loss of threonine-mediated feedback inhibition of both AKI activity and HDI activity, cause single amino acid substitutions (Gly to Asp at position 330 and Ser to Phe at position 352, respectively) in the central region of the AKI-HDI protein. The thrA1+A22 mutation of strain HNr59, which results in a threonine-sensitive AKI and a threonine-resistant HDI, also causes a single amino acid substitution (Ala to Thr at position 479).
Threonine is synthesized from L-aspartate via five enzymatic reactions. In Escherichia coli, four of the five enzyme activities of this pathway are encoded by the thrAlA2BC operon (39, 45) . The first and third steps of this pathway are catalyzed by aspartokinase I (AKI) (EC 2.7.2.4) and homoserine dehydrogenase I (HDI) (EC 1.1.1.3); these two enzymes are encoded by the thrA A2 genes in a single polypeptide chain, the AKI-HDI protein. Homoserine kinase (EC 2.7.1.39), the thrB gene product, catalyzes the fourth step. The thrC gene encodes threonine synthase (EC 4.2.99.2), which catalyzes the last step of the pathway. The nucleotide sequences of these thr genes have been reported previously (6, 19, 35) . The E. coli AKI-HDI enzyme is a large tetrameric protein (10, 19) . Proteolytic digestion has shown that the AKI and HDI activities are carried by the N-terminal and C-terminal moieties, respectively, and that multimer formation depends on the central region (11, 12) .
Threonine synthesis in Serratia marcescens has been studied extensively (22, 23) . Both AKI and HDI activities are subject to feedback inhibition by threonine, and expression of the thr operon is multivalently repressed by threonine and isoleucine. Therefore, the AKI-HDI protein is a key enzyme of this pathway in S. marcescens.
Threonine-producing isolates of S. marcescens Sr4l were obtained previously, and these organisms were found to be insensitive to feedback inhibition for HDI or for both AKI and HDI. Strains HNr21 and HNr59 are resistant to a threonine analog, 0-hydroxynorvaline (23) . Both AKI activity and HDI activity in strain HNr21 are resistant to threonine, while strain HNr59 has a threonine-sensitive AKI but a threonine-resistant HDI. These strains produce 4 to 10 g of * Corresponding author.
L-threonine per liter of fermentation medium containing sucrose and urea (22, 23) . Strain TLr156 was isolated as a threonine-resistant strain from mutants which were sensitive to threonine because of a lack of homoserine dehydrogenase II. Both AKI and HDI of strain TLr156 are highly desensitized for threonine-mediated feedback inhibition, and this strain produces about 24 g of L-threonine per liter of medium (21) ; the thrA gene has been cloned from this strain (42) . In this paper we describe the nucleotide sequences of the S. marcescens thrA genes (wild type and mutant) and the structural features of the AKI-HDI proteins.
MATERUILS AND METHODS
Bacterial strains and plasmids. The strains and plasmids which we used are listed in Table 1 . E. coli JM109 was used as a host for the construction of plasmids. We designated the thr mutations as follows: thrA l and thrA 15 , lack of feedback inhibition of AKI; thrA21, thrA22, and thrA25, lack of feedback inhibition of HDI. The rich medium which we used was Luria-Bertani medium (8) , and the minimal medium of Davis and Mingioli (7) was modified by omitting sodium citrate and adding 0.5% glucose or 0.5% glycerol as a carbon source. Required L amino acids were used at a concentration of 1 mM. Ampicillin was added at a concentration of 200 ,ug/ml.
Genetic methods and DNA sequencing analysis. DNA manipulations were carried out by using standard procedures (30) . The polymerase chain reaction was performed as described previously (16) . The nucleotide sequence was determined by the dideoxy chain termination method (40) . Nucleotide and amino acid sequence data were analyzed by786 OMORI ET AL. RNA analysis by primer extension. The thr operon mRNA was analyzed by reverse transcriptase-directed primer extension, using the synthetic 20-mer oligonucleotide 5'-CTG TGGTATCGGTGGTGGTA-3', which is complementary to a region from position +68 to position +87 of the mRNA (9) . To facilitate the detection of extended products, a pUCderived high-copy-number plasmid, pUPE18 (33) , was used. A 1.6-kb SalI-digested promoter fragment of pWT201 was cloned into the SmaI site of pUPE18, resulting in pUT-THRL. RNA extracted from recombinant cells of S. marcescens TT392 containing pUTTHR1 was enriched in this way for the transcript lacking the 3' region of the thrA coding sequence. RNA was purified by using the glass bead-hot-phenol extraction procedure and the RNase-free DNase treatment method (17, 33, 36) . 32P-labeled primer-RNA hybridizations and extension reactions were carried out as described previously (33) . The extended products were fractionated on an 8% polyacrylamide sequencing gel.
Construction of the thrA plasmids. To obtain high-level expression of the AKI-HDI protein, the thrA gene was cloned into pUC-derived expression vectors. To construct C-terminal deletions of the thrA plasmid, we used pUC1981
carrying the HindIII-KpnI-AfllI-Eco47III-SacI-HindIII restriction site and three termination codons.
The thrA plasmid, pTHRWA6, was constructed as described below. A newAflII site at position 931 was produced in the thrAA2 genes by using site-directed mutagenesis (24) . The 2.6-kb AfllI-Eco47III fragment, which encoded the Shine-Dalgamo sequence and the thrA structural gene, was inserted into the corresponding sites of pUC1981. Undirectional deletions of the thrA DNA fragment were done as described previously (50) .
N-terminal deletions of the thrA gene were constructed by using plasmid pUT18, which contains a tac promoter and an rrnBtlt2 terminator of pKK223-3. The thrA gene lacking an N-terminal moiety was obtained by using the polymerase chain reaction. The 1.1-kb fragment encoding initiator codon ATG and amino acid residues 463 to 819 was amplified from pTHRWA6, and the resulting fragment was cloned onto pUT18, generating pTHRAD202. Plasmid pTHRAD201 encoding amino acid residues 255 to 819 was constructed by inserting the 0.7-kb EcoRI-BglII fragment amplified from pTHRWA6 into EcoRI-BglII-digested pTHRAD202. The presence of the inserted DNAs was confirmed by DNA sequencing.
The mutant thrA genes of pMT301, pMT401, and pSK301, which carried the thrA1lA21, thrA1+A22, and thrA SA25 mutations, were subcloned into pUC1981 by using the strategy described above, producing pTHRM21, pTHRM59, and pTHRM156, respectively.
Assay of enzyme activity. Gln-Leu-Lys-COOH), corresponding to amino acid residues 88 to 102 of the AKI-HDI protein, was synthesized by using the t-butyloxycarbonyl synthesis strategy. To produce a specific antibody, peptide AKP was coupled to keyhole limpet hemocyanin by a glutaraldehyde reaction as described previously (15) . Polyclonal antibody toward the peptide was obtained by injecting rabbits with the peptidekeyhole limpet hemocyanin (0.5 mg) conjugate in Freund's complete adjuvant. Determination of the native molecular weights of the AKI-HDI proteins of deletion mutants. The native molecular weights of the AKI-HDI deletion proteins were estimated from the results of gel filtration on a Superose 12HR 10/30 fast-protein liquid chromatography column (10 by 300 mm; Pharmacia). Harvested cells were suspended in 0.6 ml of buffer A containing 20 mM potassium phosphate (pH 7.2), 150 mM KCl, 2 mM EDTA. K2Mg, 2 mM threonine, and 1 mM dithiothreitol and were disrupted by sonication. The cell extracts (0.2 ml) were applied to the column, which was eluted with buffer A at rate of 0.3 ml/min, and 0.225 ml-fractions were collected.
Portions of the fractions were subjected to 12.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis by using the buffer system of Laemmli (26) . The proteins were transferred electrophoretically to Immobilon P filters (Millipore), and immunostaining of the blots was performed by a peroxidase procedure (Vectastain ABC kit; Vector Laboratories, Burlingame, Calif.), using a 1:500 to 1:1,000 dilution of the antiserum against peptide AKP. The column was calibrated with the following proteins having known molecular weights: ferrtin (Mr, 440,000), aldolase (Mr, 158,000), bovine serum albumin (Mr, 67,000), ovalbumin (Mr, 43 ,000), and chymotrypsinogen A (Mr, 25, 000) . From the elution volume of an immunoreactive protein, we estimated the native molecular weights of the AKI-HDI protein derivatives.
Nucleotide sequence accession numbers. The nucleotide sequence of the S. marcescens thr operon and its flanking regions has been deposited in the GenBank, EMBL, and DDBJ nucleotide sequence data bases under accession number X60821. The nucleotide sequences of the mutant thrA genes have been deposited in the GenBank EMBL, and DDBJ nucleotide sequence data bases under accession numbers D10385, D10386, and D10387.
RESULTS AND DISCUSSION
Nucleotide sequence of the wild-type thr operon of S. marcescens. A 9.0-kb XhoI-HindIII-digested fragment carrying the thr operon of S. marcescens 8000, a wild-type isolate of strain Sr4l, was cloned into the Sall-HindIll site of pBR322 by selecting Thr+ clones derived from E. coli 490A (thrA). The resulting plasmid, pWT201, complemented the thrA1, thrA2, thrB, and thrC mutations of E. coli GT16, GT15, GT13, and GT12, respectively ( Fig. 1) . One of the deletion plasmids, pWT210, contained a 5.3-kb fragment and complemented the thrAM, thrA2, thrB, and thrC mutations, indicating that this fragment contained the entire thrAAfBC gene sequence. The locations of the thrA, thrB, and thrC genes were established by complementation tests (Fig. 1 ).
An analysis of the nucleotide sequence (6, 190 sists of 1,287 nucleotides and starts 4 nucleotides downstream from the termination codon of the second ORF. Putative Shine-Dalgarno sequences (GGAG, GGAG, and GGA) were identified upstream from the three initiation codons. These ORFs encode polypeptides consisting of 819, 309, and 429 amino acid residues with predicted Mrs of 88,494, 33,387, and 47,093, respectively; complementation tests for the deletion plasmids showed that these three ORFs are thrA, thrB, and thrC, respectively. The dyad symmetry and T-rich cluster which follows the thrC gene suggest that there is a strong stem-loop structure with a 10-bp stem and a 4-base loop. This sequence is similar to the rho-independent terminators in E. coli (38) .
Transcription initiation site and structure of the thr promoter region. Primer extension analysis was used to locate the transcription initiation site of the thr operon (Fig. 3) . Five distinct extended products were observed after the reverse transcriptase reaction by using the RNA from S. marcescens TT392 containing pUTTHR1, which carries the promoter region of the thr operon. The thr genes are transcribed from the first start site, which is located at the A residue at nucleotide 769. A computer search for the promoter sequence revealed two sequences, TTGACT and TTTAAC, which are located 35 and 10 bp upstream from this position, respectively (Fig. 2) (32) . Thus, we confirmed that these sequences, which are similar to the consensus sequence of the E. coli promoter (14) , constitute the promoter of the S. marcescens thr operon.
A short ORF that should encode an oligopolypeptide containing eight threonine residues and three isoleucine residues was found downstream from the transcription initiation site (Fig. 2) Comparison of the predicted amino acid sequences of S. marcescens AKI-HDI and E. coli AKI-HDI. The complete amino acid sequences of S. marcescens AKI-HDI (SM) (this study) and E. coli AKI-HDI (EC) (20) are shown in one-letter designations. The locations of the D-P-R motif, a region homologous to y-glutamyl kinase (34) , are indicated below the sequence by solid bars. Identical residues are indicated by boxes. To maximize homology, one gap was introduced into the sequence of the C-terminal moiety of the S. marcescens AKI-HDI. symmetry structures, which was centered at nucleotide 908, resembled a terminator structure. This structure is similar to a typical transcriptional attenuator (27, 28) found in the E. coli thr operon (13, 29) .
Comparisons of amino acid sequences in S. marcescens and E. coli. A comparison of the deduced amino acid sequences of the leader peptides and the thrA, thrB, and thrC gene products of S. marcescens and E. coli revealed levels of identity of 64, 83, 73, and 84%, respectively. The D-P-R sequence, a region homologous to -y-glutamyl kinase (33) , was identified in the N-terminal moiety of the AKI-HDI protein (amino acid residues 220 to 245), suggesting that the N-terminal moiety of the AKI-HDI protein is responsible for AKI activity (Fig. 4) .
Threonine-mediated feedback inhibition of the truncated AKI-HDI. We examined the allosteric response to threonine of the truncated AKI-HDI molecules by using high-level expression in a plasmid derived from pUC, pUC1981. The levels of AKI activity of the truncated AKI-HDI molecules were one-third to one-fourth of the level encoded by the wild-type plasmid, whose AKI and HDI activities were 94 and 93% inhibited in the presence of 50 and 100 mM L-threonine, respectively (Fig. 5) .
Molecules truncated at the C-terminus lacked HDI activity, but exhibited fairly good threonine-sensitive AKI activity as long as they still had the residues up to residue 468 5 . Construction of the thrA deletion plasmids and threonine-mediated feedback inhibition of the truncated AKI-HDI enzymes. Additional amino acid residues that were generated by the construction of plasmids are indicated by one-letter designations on the right and left sides of the positions of amino acid residues for C-terminal and N-terminal extensions, respectively. E. coli GT16 (thrAj) and GT15 (thrA2) were used as hosts for complementation tests. Cell extracts from E. coli GT16 and MM294 carrying the plasmid were used for the assays of AKI and HDI activities, respectively. Also shown are feedback inhibition data for AKI and HDI activities in the presence of 50 and 100 mM L-threonine, respectively. The levels of AKI activity and HDI activity for the strains carrying pTHRWA6 were 190 and 170 U, and the levels of activity for the host strains were 3 to 4% of the levels of activity for the recombinant strains (6.1 and 6.5 U, respectively). NT, not tested.
amino acid residues 255 to 819, complemented the thrA2 mutation of E. coli GT15. The level of HDI activity encoded by this plasmid was one-tenth of the level encoded by the wild-type plasmid, and this activity was not sensitive to threonine. Plasmid pTHRAD201, which encodes amino acid residues 463 to 819, did not complement the thrA2 mutation, and HDI activity was not detected when this plasmid was examined. These findings showed that the AKI activity is carried by the N-terminal moiety and the HDI activity is carried by the central and C-terminal moiety. Thus, the S. marcescens AKI-HDI is similar to the E. coli AKI-HDI (46, 47) in structure.
Estimation of the native molecular weight of the AKI-HDI protein. The native molecular weights of the AKI-HDI deletion proteins were estimated by gel filtration ( (immunoblotting) in which antibody against a synthetic peptide, AKP, was used. The native molecular weight of the normal AKI-HDI protein was 280,000 to 370,000. This was consistent with the hypothesis that it is a tetramer like the E. coli enzyme (10, 12) . The truncated AKI-HDI molecules containing the N-terminal 462 and 468 amino acid residues were probably dimeric, and the shorter molecules were probably monomeric.
Threonine sensitivities of the AKI-HDI enzymes encoded by the mutant thrA plasmids. The mutant thrA15A25 operon of a threonine-producing mutant, TLr156, was cloned previously and was designated pSK301 (42) , and the other mutant thr operons, which were obtained from strains HNr21 and HNr59, were cloned as 9.0-kb fragments. Plasmids pMT301 and pMT401 carried the thrA1lA21 and thrA1+A22 mutations, respectively. Subcloning in pUC1981 gave pTHRM21, pTHRM59, and pTHRM156, which were introduced into E. coli GT16 for the AKI assay and into E. coli MM294 for the HDI assay to confirm the allosteric response for threonine of the encoded AKI-HDI molecules (Fig. 6 ). Plasmids (19) , the four C-terminal regions of E. coli aspartokinase III (AKIII) (4), Saccharomyces cerevisiae aspartokinase (AK) (37), Bacillus subtilis aspartokinase II (AKII) and homoserine dehydrogenase (5, 34) , Corynebactenium glutamicum aspartokinase (AK) and homoserine dehydrogenase (18, 36) , and E. coli aspartokinase II-homoserine dehydrogenase II (AKII-HDII) (51) are shown. Identical residues and alterations (I = L = V = M = F, D = E, N = Q, R = K, and S = T) which are conserved in more than 60% of the enzymes are shaded. Gaps were introduced to maximize homology. The sequence G-X-G-X-X-G (48, 49) is indicated by boxes. The positions of mutations and the amino acid substitutions of mutants HNr21 (thrAjlA2J), TLr156 (thrA15A25), and HNr59 (thrAj+A22) are indicated above the S. marcescens sequence with arrows. The mutation in the lysCIRFB gene of C. glutamicum DM58-1 (18) is enclosed in a box and is indicated by an arrow. pTHRM21 and pTHRM156, which carried the thrA1lA21 and thrA15A25 genes, respectively, coded for threonineresistant AKI and HDI. The HDI activity of the thrA15A25 AKJ-HDI protein was less sensitive to threonine than the thrA1lA21 AKI-HDI was. The AKI-HDI which was encoded by the thrA1+A22 genes was composed of threonine-sensitive AKI and threonine-resistant HDI. These observations coincided with the facts reported previously (20) , and we confirmed that these mutant thrA$A2 plasmids encoded the mutant AKI-HDI molecules in the threonine-producing strains.
Base substitutions of the mutant thrAlA2 genes. The nucleotide sequences of the thrA1A2 coding regions of pMT301, pMT401, and pSK301 were determined. A comparison of the nucleotide sequences of these thrA genes revealed that one base substitution occurred in each of the thrA1lA21 and thrA1+A22 genes and four base substitutions occurred in the thrAl5A25 genes. The resulting amino acid substitutions are shown in Fig. 7 .
The thrA1lA21 mutation was a transversion of G C to A. T at nucleotide 989 in the AKI-HDI coding region. From this base change we predicted a single amino acid substitution (Gly to Asp at position 330). The thrA1+A22 mutation was a transversion of G. C to A. T at nucleotide 1435, which resulted in a single amino acid replacement (Ala to Thr at position 479). This change is located near the sequence G-X-G-X-X-G (amino acid residues 472 to 477), which is a Iot4-fold that is responsible for the binding of the ADP moiety of NADP, a cofacter of HDI (48, 49) , and may cause a local conformational change in the active site of HDI. The base changes from G. C to A. T found in the thrA15A2S5 genes were located at nucleotides 462, 1055, 1438, and 1471. The base change at nucleotide 1055 led to a change in the predicted amino acid sequence at position 352 from Ser to Phe; the other base changes occurred at the first or third nucleotide of a Leu codon, resulting in no amino acid changes. In each of the three mutants the single amino acid substitution was located in the central region of AKI-HDI. No base substitutions were observed in the promoter and attenuator regions. These two amino acid substitutions occur in a single hydrophobic loop in the central region of the protein, which is conserved in a family of aspartokinases, and seem to be involved in the allosteric response in some way (Fig. 7) . Interestingly, a mutation in the aspartokinase of a Corynebacterium glutamicum mutant resistant to lysine and threonine (18) is a substitution of Tyr for Ser in the same position as amino acid residue 352.
The final goal of our research is a better understanding of the allosteric response of both AKI and HDI encoded in a single polypeptide. We are currently examining the effects of the amino acid substitutions at position 352 on the allosteric response of AKI-HDI by using site-directed mutagenesis.
